Stay updated on Nivolumab ± Ipilimumab in Ovarian Cancer Clinical Trial
Sign up to get notified when there's something new on the Nivolumab ± Ipilimumab in Ovarian Cancer Clinical Trial page.

Latest updates to the Nivolumab ± Ipilimumab in Ovarian Cancer Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe page has updated the name of the medical center to 'MaineHealth Maine Medical Center- Scarborough' and has revised the version number to v2.15.2. Additionally, several older dates and the previous version number v2.15.0 have been removed.SummaryDifference0.3%
- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedThe page has been updated to include new identifiers and collaborators related to clinical trials for recurrent ovarian and fallopian tube cancers, while significant details about the trial's objectives and treatment protocols have been removed.SummaryDifference40%
- Check30 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.0%
- Check37 days agoChange DetectedThe page has been updated to reflect a new last update date of March 30, 2025, and a revision change to version 2.14.3. The previous last update date and revision have been removed.SummaryDifference0.1%
- Check44 days agoChange DetectedThe webpage has updated its healthcare facility listings, replacing some locations with new ones, including AdventHealth Littleton and Parker, while removing others like Littleton Adventist Hospital and Parker Adventist Hospital.SummaryDifference0.6%
- Check52 days agoChange DetectedThe page has updated its date references and removed the mention of FHCC South Lake Union, while adding the Fred Hutchinson Cancer Center as a key entity.SummaryDifference0.3%
Stay in the know with updates to Nivolumab ± Ipilimumab in Ovarian Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab ± Ipilimumab in Ovarian Cancer Clinical Trial page.